Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family member C19 pseudogene 6 (DNAJC19P6) is a human pseudogene corresponding to a non-functional copy of the DnaJ/Hsp40 family chaperone gene. Pseudogenes such as DNAJC19P6 arise via gene duplication or retrotransposition but have acquired mutations or other genomic changes that prevent them from encoding functional proteins[2][6]. While many pseudogenes are transcriptionally silent, some can be transcribed into non-coding RNAs with potential regulatory impacts, such as modulating the expression of their protein-coding counterparts or acting as endogenous RNA decoys. However, there are no available scientific data indicating that DNAJC19P6 is expressed as RNA, regulates other genes, or participates in disease. It has no established use as a drug target or biomarker. Its primary scientific relevance is as a genomic feature reflecting evolutionary processes[2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member C19 pseudogene 6 (DNAJC19P6).